Wolfe Research analyst Steven Chubak upgraded Carlyle (CG) to Outperform from Peer Perform with a $60 price target without a price target as part of a 2025 playbook for the brokers, asset managers, and exchanges. The firm is “getting selective as valuations look stretched.” After a “banner year” for financials, Wolfe is most positive on names with secular growth stories and exposure to “Trump tailwinds,” the analyst tells investors in a research note. Wolfe is “growing more confident” in the upside case for Carlyle, saying an improving private equity backdrop should drive accelerating realization activity and increased buybacks, supporting multiple convergence with peers.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CG:
- Carlyle price target raised to $59 from $57 at Barclays
- Medline Industries Could Launch a $5B IPO in 2025
- Carlyle price target raised to $85 from $78 at Oppenheimer
- Carlyle price target raised to $61 from $56 at Deutsche Bank
- Carlyle price target raised to $49 from $43 at TD Cowen
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
